Circulating matrix metalloproteinase levels after ventricular septal defect repair in infants
Authors:
Open Access
- 31 December 2010
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 140 (6) , 1257-1265
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Inhibition of matrix metalloproteinase activity in vivo protects against vascular hyporeactivity in endotoxemiaAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in diseaseBlood, 2009
- Matrix metalloproteinases and their inhibitors as biomarkers of severity in sepsisCritical Care, 2009
- Endothelin-A Receptor Inhibition After Cardiopulmonary Bypass: Cytokines and Receptor ActivationThe Annals of Thoracic Surgery, 2008
- Collagenase‐2 (MMP‐8) and matrilysin‐2 (MMP‐26) expression in human wounds of different etiologiesWound Repair and Regeneration, 2007
- Steroid use before pediatric cardiac operations using cardiopulmonary bypass: An international survey of 36 centers*Pediatric Critical Care Medicine, 2005
- Neutrophil-Mediated Secretion and Activation of Matrix Metalloproteinase-9 During Cardiac Surgery with Cardiopulmonary BypassAnesthesia & Analgesia, 2005
- Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of ϵ-aminocaproic acid and aprotininThe Journal of Thoracic and Cardiovascular Surgery, 2003
- Resident Cardiac Mast Cells Degranulate and Release Preformed TNF-α, Initiating the Cytokine Cascade in Experimental Canine Myocardial Ischemia/ReperfusionCirculation, 1998
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998